{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:47:35Z","timestamp":1794433655191,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-020"],"award-info":[{"award-number":["2021-I2M-1-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871011"],"award-info":[{"award-number":["81871011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930104"],"award-info":[{"award-number":["81930104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101545"],"award-info":[{"award-number":["82101545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171447"],"award-info":[{"award-number":["82171447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021ZD0200600"],"award-info":[{"award-number":["2021ZD0200600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021ZD0202000"],"award-info":[{"award-number":["2021ZD0202000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021ZD0203000"],"award-info":[{"award-number":["2021ZD0203000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.eplepsyres.2023.107095","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:51:19Z","timestamp":1674705079000},"page":"107095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Long-term outcomes of classic and novel anti-seizure medication in a kainate-induced model of chronic epilepsy"],"prefix":"10.1016","volume":"191","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longze","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2660-8092","authenticated-orcid":false,"given":"Qi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2023.107095_bib1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/epi.16955","article-title":"Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital","volume":"62","author":"Barker-Haliski","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/seiz.2000.0499","article-title":"Course of chronic focal epilepsy resistant to anticonvulsant treatment","volume":"10","author":"Bauer","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(85)90299-4","article-title":"Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy","volume":"14","author":"Ben-Ari","year":"1985","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"10.1016\/j.eplepsyres.2023.107095_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yebeh.2008.09.017","article-title":"Temporal lobe epilepsy: where do the seizures really begin","volume":"14","author":"Bertram","year":"2009","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3906\/sag-1806-236","article-title":"Demonstration of the effect of brivaracetam on an experimental epilepsy model","volume":"48","author":"\u00c7etiner","year":"2018","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib6","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1528-1167.2009.02412.x","article-title":"Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP","volume":"51","author":"Chang","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cns.12523","article-title":"Differential effects of antiepileptic drugs on focal seizures in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy","volume":"22","author":"Duveau","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/j.1528-1167.2007.01263.x","article-title":"Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols","volume":"48","author":"Grabenstatter","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682767","article-title":"Perampanel reduces hyperthermia-induced seizures in dravet syndrome mouse model","volume":"12","author":"Ho","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib10","first-page":"9","article-title":"The integrated effects of brivaracetam, a selective analog of levetiracetam, on ionic currents and neuronal excitability","author":"Hung","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s11064-017-2275-z","article-title":"The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)","volume":"42","author":"Kehne","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2014.11.008","article-title":"Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice","volume":"90","author":"Klein","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib16","doi-asserted-by":"crossref","unstructured":"Ostendorf, A.P., Wong, M., 2015. mTOR inhibition in epilepsy: Rationale and clinical perspectives. CNS drugs 29, 91\u201399. 10.1007\/s40263\u2013014-0223-x.","DOI":"10.1007\/s40263-014-0223-x"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib17","first-page":"9","article-title":"Hippocampal low-frequency stimulation prevents seizure generation in a mouse model of mesial temporal lobe epilepsy","author":"Paschen","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197713020-00001","article-title":"Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.09.015","article-title":"The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats","volume":"103","author":"Rattka","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yebeh.2017.11.019","article-title":"Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model","volume":"79","author":"Sanon","year":"2018","journal-title":"Epilepsy Behav.: EB"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.20160667","article-title":"Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy","volume":"214","author":"Sha","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0306-4522(83)90113-6","article-title":"Kainic acid induced seizures: Neurochemical and histopathological changes","volume":"10","author":"Sperk","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib24","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.0013-9580.2003.32803.x","article-title":"Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH\/NINDS\/AES models II workshop","volume":"44","author":"Stables","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108297","article-title":"Novel brain permeant mTORC1\/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex","volume":"180","author":"Theilmann","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuropharm.2015.03.014","article-title":"The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy","volume":"95","author":"Twele","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11064-017-2239-3","article-title":"A mesiotemporal lobe epilepsy mouse model","volume":"42","author":"Venceslas","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12035-015-9590-7","article-title":"Deletion of mTOR in reactive astrocytes suppresses chronic seizures in a mouse model of temporal lobe epilepsy","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/epi.16406","article-title":"A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies","volume":"61","author":"Welzel","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2023.107095_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105227","article-title":"Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy","volume":"149","author":"Welzel","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2023.107095_bib31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1523\/JNEUROSCI.0980-08.2009","article-title":"Development of spontaneous recurrent seizures after kainate-induced status epilepticus","volume":"29","author":"Williams","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121123000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121123000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:48:19Z","timestamp":1760276899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121123000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"alternative-id":["S0920121123000207"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107095","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of classic and novel anti-seizure medication in a kainate-induced model of chronic epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107095"}}